Popularity #2,205Earnings are out
ANAB · NASDAQ · Biotechnology

AnaptysBio (ANAB)

Manages Jemperli and imsidolimab royalties through GSK and Vanda partnerships.

$51.42
vs last close−2.50 (−4.64%)